Hier finden Sie grundlegende Angaben zu klinischen Studien des Comprehensice Cancer Centers Mainfranken (CCC MF)
Filter aktiv
Seite 1 - Studien 1 bis 2 von insgesamt 2
- Rekrutierung läuftA Phase 2b Randomized, Double-blind, Active- and Placebo-controlled, Parallel-group,
Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance
Combination Therapy with Guselkumab and Golimumab in Participants with Moderately
to Severely Active Crohn’s Disease - Rekrutierung läuftA Phase 2b Randomized, Double-blind, Active- and Placebo-controlled, Parallel-group,
Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance
Combination Therapy with Guselkumab and Golimumab in Participants with Moderately
to Severely Active Ulcerative Colitis